Clinical Trial Update: Metformin Inhibits DNMT3A Clonal Hematopoiesis in Acute Leukemia [Phase 1]

View source ↗

Summary

A Phase 1 trial is investigating whether metformin can inhibit DNMT3A-mutant clonal hematopoiesis in acute leukemia; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: DNMT3A Gene Mutation | Phase 1 | Status: NOT_YET_RECRUITING